重新思考水炎辅助性管理:细菌相互作用和治疗演变的洞察力
Faith D Huynh1, Giovanni Damiani2,3, Christopher G Bunick4
1Yale School of Medicine, New Haven, CT 06510, USA.
Antibiotics (Basel, Switzerland)
|March 27, 2024
概括
补腺炎 (HS) 是一种慢性皮肤疾病,涉及痛苦的结节和. 未来的治疗方法可能将抗炎疗法与管理细菌失衡的方法结合起来.
科学领域:
- 皮肤病学 皮肤病学
- 微生物学 微生物学
背景情况:
- 补腺炎 (HS),也被称为反向,是一种慢性炎症性皮肤疾病.
- 它会导致反复出现的,痛苦的结节和,严重影响患者的生活质量.
- HS通常会影响下,沟和乳下区域等区域,可能导致囊和鼻道.
研究的目的:
- 审查HS和细菌微生物群之间的相互作用.
- 讨论当前的HS治疗方法及其对相关细菌的影响.
- 探索HS的创新治疗策略.
主要方法:
- 文献综述,重点关注HS病原和微生物关联.
- 分析现有的治疗方式及其对细菌群落的影响.
- 确定新出现的治疗点.
主要成果:
- HS的发病因子是多因素的,并未完全理解.
- 皮肤失生症在HS发病或进展中的作用需要进一步研究.
- 目前的治疗方法可能会影响与HS相关的细菌,但需要有针对性的调制.
结论:
- 有效的HS管理可能需要解决炎症和微生物失生症.
- 未来的疗法可能将先进的抗炎策略与微生物组调节相结合.
- 与炎症一起准细菌失衡提供了一个有希望的治疗途径.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Gastritis III: Clinical Manifestations and Management
235
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
235
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
390
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
390
Irritable Bowel Syndrome III: Medical and Nursing Management
201
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
201


